# Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus

> **NCT03317301** · PHASE3 · COMPLETED · sponsor: **Hanlim Pharm. Co., Ltd.** · enrollment: 189 (actual)

## Conditions studied

- Pruritus

## Interventions

- **DRUG:** HL151
- **DRUG:** Talion Tab

## Key facts

- **NCT ID:** NCT03317301
- **Lead sponsor:** Hanlim Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-17
- **Primary completion:** 2017-11-13
- **Final completion:** 2018-01-30
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2018-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03317301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03317301, "Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03317301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*